Investigating the Possibility of Biomarkers in Order to Correctly Prescribe ADCs Dependent on Individual Patient Response to Toxicities

Time: 12:15 pm
day: Conference Day 1


  • Discovering the possibility of biomarkers to understand amount/application of ADC dosing dependent on patient screening results
  • Looking at patient-dependent liabilities to toxicities to decide on whether the prescription of an ADC would be beneficial.
  • Identifying which biomarkers are indicative of higher toxicity levels